Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Palvella Therapeutics (NASDAQ:PVLA – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for Palvella Therapeutics in a research report ...

Page Six is bringing Swifties the daily lowdown on everything Taylor Swift, from music news to fan theories and glimpses into her relationship with Travis Kelce. The singer celebrated the end of ...

Taylor Swift and Travis Kelce marked the end of her record-breaking Eras Tour with a night to remember, joining friends Patrick and Brittany Mahomes for a dazzling themed celebration in Kansas City.

Magazine. Ashok Kumar/TAS24/Getty It's the end of an era for Taylor Swift! The pop superstar — who turned 35 on Friday, Dec. 13 —celebrated her latest achievements alongside boyfriend Travis ...

For Taylor Swift and Travis Kelce, 2024 was a year full of personal, professional and romantic highs. The couple — who began dating in summer 2023 — started and ended 2024 on positive notes.

Brandon Lutnick, a trader at his father’s Cantor Fitzgerald LP, has been listed as CEO at its most recently created SPAC, Cantor Equity Partners I Inc., according to a filing Wednesday.

Cantor Fitzgerald CEO Howard Lutnick, the president-elect’s pick for commerce secretary, has purchased the Washington, D.C., home of Fox News anchor Bret Baier for $25 million.

Cantor Fitzgerald analyst Andres Sheppard reiterated a Buy rating on Archer Aviation (ACHR – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at ...

Cantor Fitzgerald analyst Kristen Kluska initiated coverage of Esperion (ESPR) with an Overweight rating and $8 price target. The company markets the oral ATP-citrate lyase inhibitors, Nexletol ...

On Tuesday, Cantor Fitzgerald initiated coverage on Esperion (NASDAQ:ESPR) Therapeutics, a biopharmaceutical company, with an Overweight rating and a price target of $8.00. The firm pointed out ...

Cantor Fitzgerald initiated coverage of Aquestive Therapeutics (AQST) with an Overweight rating and $17 price target Th company’s “secret sauce” is developing products with its oral film ...